(Q44805912)

6 December 2017

Obesity among individuals with serious mental illness (English)

1 reference

6 December 2017

0 references

7

L B Dixon

1 reference

6 December 2017

F B Dickerson

1

1 reference

6 December 2017

C H Brown

2

1 reference

6 December 2017

J A Kreyenbuhl

3

1 reference

6 December 2017

L Fang

4

1 reference

6 December 2017

R W Goldberg

5

1 reference

6 December 2017

K Wohlheiter

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Acta Psychiatrica Scandinavica

6 December 2017

1 reference

6 December 2017

113

1 reference

6 December 2017

4

1 reference

6 December 2017

306-313

1 reference

Years of life lost due to obesity

6 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Actual Causes of Death in the United States, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Changes in body mass index for individuals with and without schizophrenia, 1987–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

The impact of weight gain on quality of life among persons with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Body mass index and quality of life in community-dwelling patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Obesity as a risk factor for antipsychotic noncompliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Schizophrenia and weight management: a systematic review of interventions to control weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Patient and direct-care staff body mass index in a state mental hospital: implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Weight gain profiles of new anti-psychotics: public health consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2005.00637.X

10.1111/J.1600-0447.2005.00637.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference